These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

373 related items for PubMed ID: 24982312

  • 1. Histamine-2-receptor antagonist administration and gastrointestinal bleeding when used for stress ulcer prophylaxis in patients with severe sepsis or septic shock.
    Barletta JF.
    Ann Pharmacother; 2014 Oct; 48(10):1276-81. PubMed ID: 24982312
    [Abstract] [Full Text] [Related]

  • 2. Are Proton Pump Inhibitors More Effective Than Histamine-2-Receptor Antagonists for Stress Ulcer Prophylaxis in Critically Ill Patients? A Systematic Review and Meta-Analysis of Cohort Studies.
    He N, Yan Y, Su S, Ge Q, Zhai S.
    Ann Pharmacother; 2022 Sep; 56(9):988-997. PubMed ID: 34971320
    [Abstract] [Full Text] [Related]

  • 3. PPIs Prevent Aspirin-Induced Gastrointestinal Bleeding Better than H2RAs. A Systematic Review and Meta-analysis.
    Szabó IL, Mátics R, Hegyi P, Garami A, Illés A, Sarlós P, Bajor J, Szűcs A, Mosztbacher D, Márta K, Szemes K, Csekő K, Kővári B, Rumbus Z, Vincze Á.
    J Gastrointestin Liver Dis; 2017 Dec; 26(4):395-402. PubMed ID: 29253055
    [Abstract] [Full Text] [Related]

  • 4. Histamine-2 receptor antagonists vs proton pump inhibitors on gastrointestinal tract hemorrhage and infectious complications in the intensive care unit.
    MacLaren R, Reynolds PM, Allen RR.
    JAMA Intern Med; 2014 Apr; 174(4):564-74. PubMed ID: 24535015
    [Abstract] [Full Text] [Related]

  • 5. Effect of proton pump inhibitors versus histamine-2 receptor antagonists on acute kidney injury in septic patients at high risk for developing stress ulcers.
    Fan HP, Zhou Y, Chen ML, Qiu KH, Feng X, Zhou C, Zhu ML, Huang RZ, Hu TY.
    Pharmacotherapy; 2024 Jul; 44(7):539-548. PubMed ID: 38899757
    [Abstract] [Full Text] [Related]

  • 6. Stress ulcer prophylaxis with proton pump inhibitors or histamine 2 receptor antagonists in critically ill adults - a meta-analysis of randomized controlled trials with trial sequential analysis.
    Zhou X, Fang H, Xu J, Chen P, Hu X, Chen B, Wang H, Hu C, Xu Z.
    BMC Gastroenterol; 2019 Nov 21; 19(1):193. PubMed ID: 31752703
    [Abstract] [Full Text] [Related]

  • 7. Cost-Effectiveness of Histamine2 Receptor Antagonists Versus Proton Pump Inhibitors for Stress Ulcer Prophylaxis in Critically Ill Patients.
    Hammond DA, Kathe N, Shah A, Martin BC.
    Pharmacotherapy; 2017 Jan 21; 37(1):43-53. PubMed ID: 27809338
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of gastrointestinal bleeding prophylaxis in critically ill patients: an updated systematic review and network meta-analysis of randomized trials.
    Wang Y, Ge L, Ye Z, Siemieniuk RA, Reintam Blaser A, Wang X, Perner A, Møller MH, Alhazzani W, Cook D, Guyatt GH.
    Intensive Care Med; 2020 Nov 21; 46(11):1987-2000. PubMed ID: 32833040
    [Abstract] [Full Text] [Related]

  • 9. A Comparison of Histamine Receptor Antagonists Versus Proton Pump Inhibitor Gastrointestinal Ulcer Prophylaxis in Kidney Transplant Recipients.
    Rouse GE, Hardinger K, Tsapepas D, Tichy EM.
    Prog Transplant; 2017 Mar 21; 27(1):4-9. PubMed ID: 27650918
    [Abstract] [Full Text] [Related]

  • 10. A pragmatic assessment of proton pump inhibitors vs. histamine type 2 receptor antagonists on clinically important gastrointestinal bleeding and mortality when used for stress ulcer prophylaxis in the ICU.
    Boyd C, Hassig T, MacLaren R.
    Pharmacotherapy; 2021 Oct 21; 41(10):820-827. PubMed ID: 34478588
    [Abstract] [Full Text] [Related]

  • 11. Gastrointestinal bleeding prophylaxis for critically ill patients: a clinical practice guideline.
    Ye Z, Reintam Blaser A, Lytvyn L, Wang Y, Guyatt GH, Mikita JS, Roberts J, Agoritsas T, Bertschy S, Boroli F, Camsooksai J, Du B, Heen AF, Lu J, Mella JM, Vandvik PO, Wise R, Zheng Y, Liu L, Siemieniuk RAC.
    BMJ; 2020 Jan 06; 368():l6722. PubMed ID: 31907223
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of gastrointestinal bleeding prophylaxis in critically ill patients: systematic review and network meta-analysis.
    Wang Y, Ye Z, Ge L, Siemieniuk RAC, Wang X, Wang Y, Hou L, Ma Z, Agoritsas T, Vandvik PO, Perner A, Møller MH, Guyatt GH, Liu L.
    BMJ; 2020 Jan 06; 368():l6744. PubMed ID: 31907166
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Stress ulcer prophylaxis versus placebo or no prophylaxis in adult hospitalised acutely ill patients-protocol for a systematic review with meta-analysis and trial sequential analysis.
    Marker S, Perner A, Wetterslev J, Barbateskovic M, Jakobsen JC, Krag M, Granholm A, Anthon CT, Møller MH.
    Syst Rev; 2017 Jun 24; 6(1):118. PubMed ID: 28646925
    [Abstract] [Full Text] [Related]

  • 18. Clinical Outcomes of Acid Suppressive Therapy Use in Hematology/Oncology Patients at an Academic Medical Center.
    McCaleb RV, Gandhi AS, Clark SM, Clemmons AB.
    Ann Pharmacother; 2016 Jul 24; 50(7):541-7. PubMed ID: 27091869
    [Abstract] [Full Text] [Related]

  • 19. Effect of Stress Ulcer Prophylaxis With Proton Pump Inhibitors vs Histamine-2 Receptor Blockers on In-Hospital Mortality Among ICU Patients Receiving Invasive Mechanical Ventilation: The PEPTIC Randomized Clinical Trial.
    PEPTIC Investigators for the Australian and New Zealand Intensive Care Society Clinical Trials Group, Alberta Health Services Critical Care Strategic Clinical Network, and the Irish Critical Care Trials Group, Young PJ, Bagshaw SM, Forbes AB, Nichol AD, Wright SE, Bailey M, Bellomo R, Beasley R, Brickell K, Eastwood GM, Gattas DJ, van Haren F, Litton E, Mackle DM, McArthur CJ, McGuinness SP, Mouncey PR, Navarra L, Opgenorth D, Pilcher D, Saxena MK, Webb SA, Wiley D, Rowan KM.
    JAMA; 2020 Feb 18; 323(7):616-626. PubMed ID: 31950977
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.